HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Claude Reubi Selected Research

Neuropeptide Y Receptors (Neuropeptide Y Receptor)

9/2011Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.
8/2008Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
7/2005Neuropeptide Y receptors in renal cell carcinomas and nephroblastomas.
12/2004High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
1/2004Neuropeptide Y receptor expression in human primary ovarian neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean Claude Reubi Research Topics

Disease

92Neoplasms (Cancer)
03/2019 - 01/2002
27Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2018 - 04/2002
23Insulinoma
09/2020 - 05/2003
7Neoplasm Metastasis (Metastasis)
01/2015 - 05/2002
5Pituitary Neoplasms (Pituitary Adenoma)
01/2018 - 07/2003
5Adenocarcinoma
02/2014 - 02/2003
4Brain Neoplasms (Brain Tumor)
01/2017 - 01/2005
4Prostatic Neoplasms (Prostate Cancer)
01/2014 - 07/2006
4Breast Neoplasms (Breast Cancer)
01/2013 - 01/2004
4Thyroid Neoplasms (Thyroid Cancer)
01/2013 - 01/2007
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2012 - 12/2011
3Nesidioblastosis (Nesidioblastosis of Pancreas)
09/2020 - 12/2015
3Meningioma (Meningiomas)
08/2008 - 07/2003
3Gastrinoma
08/2007 - 05/2003
3Pheochromocytoma
05/2007 - 12/2004
3Ovarian Neoplasms (Ovarian Cancer)
01/2007 - 01/2004
3Paraganglioma (Paragangliomas)
12/2005 - 07/2003
3Neuroblastoma
12/2005 - 07/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2003 - 05/2003
2Hyperplasia
01/2020 - 01/2011
2Renal Cell Carcinoma (Grawitz Tumor)
01/2013 - 07/2005
2Urologic Neoplasms (Urological Cancer)
01/2013 - 06/2009
2Lymphoma (Lymphomas)
01/2013 - 05/2007
2Leiomyosarcoma
02/2012 - 08/2008
2Hepatocellular Carcinoma (Hepatoma)
02/2012 - 12/2006
2Cholangiocarcinoma
02/2012 - 12/2006
2Carcinoma (Carcinomatosis)
04/2010 - 05/2007
2Ewing Sarcoma (Sarcoma, Ewing)
08/2008 - 08/2004
2Glioma (Gliomas)
08/2008 - 06/2006
2Glioblastoma (Glioblastoma Multiforme)
08/2008 - 06/2006
2Carcinoid Tumor (Carcinoid)
01/2007 - 01/2004
2Ulcer
04/2006 - 03/2004
2Stomach Ulcer (Gastric Ulcer)
04/2006 - 03/2004
2Medulloblastoma
12/2005 - 07/2003
2Lung Neoplasms (Lung Cancer)
09/2004 - 07/2003
2Sarcoma (Soft Tissue Sarcoma)
08/2004 - 07/2003
1Amaurosis Fugax
01/2017
1Stroke (Strokes)
01/2017
1Transient Ischemic Attack
01/2017
1Pancreatic Ductal Carcinoma
01/2015

Drug/Important Bio-Agent (IBA)

38Somatostatin Receptors (Somatostatin Receptor)IBA
01/2018 - 05/2002
28Peptide Receptors (Peptide Receptor)IBA
06/2015 - 05/2003
25Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2018 - 05/2002
23Peptides (Polypeptides)IBA
03/2019 - 01/2002
18BombesinIBA
03/2019 - 04/2002
17Bombesin Receptors (Bombesin Receptor)IBA
03/2019 - 04/2002
16Glucagon-Like Peptide 1 (GLP 1)IBA
01/2016 - 05/2003
13LigandsIBA
04/2015 - 09/2002
121,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2016 - 05/2002
12Octreotide (Sandostatin)FDA LinkGeneric
03/2013 - 05/2002
10Messenger RNA (mRNA)IBA
02/2012 - 04/2002
9Glucagon-Like Peptide-1 ReceptorIBA
09/2020 - 12/2006
8Radioisotopes (Radionuclides)IBA
03/2019 - 02/2007
8Neuropeptide YIBA
09/2011 - 01/2004
6Proteins (Proteins, Gene)FDA Link
02/2012 - 04/2002
6Gastrin-Releasing PeptideIBA
07/2011 - 04/2002
5Exenatide (Byetta)FDA Link
12/2015 - 12/2006
5Cholecystokinin B ReceptorIBA
06/2015 - 07/2003
5Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA
09/2011 - 01/2004
5Cholecystokinin (Pancreozymin)IBA
11/2008 - 07/2003
4Biological ProductsIBA
03/2019 - 08/2005
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2017 - 01/2008
4gastric inhibitory polypeptide receptorIBA
01/2015 - 01/2011
4IncretinsIBA
06/2014 - 01/2011
4GastrinsIBA
09/2011 - 01/2007
4AcidsIBA
06/2009 - 06/2006
4Hormones (Hormone)IBA
01/2007 - 12/2004
3AntibodiesIBA
01/2018 - 12/2005
3NeurotensinIBA
01/2015 - 01/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2013 - 04/2005
3Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
02/2012 - 07/2003
3somatostatin receptor sst2AIBA
01/2010 - 12/2005
3Peptide YYIBA
08/2008 - 01/2004
3secretin receptorIBA
08/2007 - 10/2005
3Substance PIBA
06/2006 - 05/2003
2Biomarkers (Surrogate Marker)IBA
01/2016 - 07/2011
21- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
01/2016 - 05/2002
2Neurotensin Receptors (Neurotensin Receptor)IBA
01/2015 - 01/2002
2Pentetic Acid (DTPA)FDA LinkGeneric
10/2013 - 12/2006
2Glucagon-Like Peptides (Enteroglucagon)IBA
11/2012 - 08/2008
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2012 - 11/2008
2Chelating AgentsIBA
08/2010 - 05/2002
2NeuropeptidesIBA
08/2008 - 08/2005
2SecretinFDA Link
12/2006 - 10/2005
2Protein Isoforms (Isoforms)IBA
04/2006 - 10/2005
2Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
01/2005 - 07/2003
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
03/2004 - 05/2003
1Blood Glucose (Blood Sugar)IBA
09/2020
168Ga-DOTA-exendin-4IBA
01/2020
1Neprilysin (Neutral Endopeptidase)IBA
03/2019
1minigastrinIBA
06/2015
1EstersIBA
01/2015
1SR 48692IBA
01/2015
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
06/2014
1GelatinIBA
06/2014

Therapy/Procedure

32Therapeutics
01/2020 - 05/2003
18Radiotherapy
01/2015 - 07/2003
2Aftercare (After-Treatment)
05/2013 - 01/2007
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2020
1Carotid Endarterectomy
01/2017